1. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Issue 4 (April 2017) Authors: Morris, Van K; Salem, Mohamed E; Nimeiri, Halla; Iqbal, Syma; Singh, Preet; Ciombor, Kristen; Polite, Blase; Deming, Dustin; Chan, Emily; Wade, James L; Xiao, Lianchun; Bekaii-Saab, Tanios; Vence, Luis; Blando, Jorge; Mahvash, Armeen; Foo, Wai Chin; Ohaji, Chimela; Pasia, Manolo; Bland, Gail; Ohi... Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406). Issue 4 (1st February 2021) Authors: Kopetz, Scott; Guthrie, Katherine A.; Morris, Van K.; Lenz, Heinz-Josef; Magliocco, Anthony M.; Maru, Dipen; Yan, Yibing; Lanman, Richard; Manyam, Ganiraju; Hong, David S.; Sorokin, Alexey; Atreya, Chloe E.; Diaz, Luis A.; Allegra, Carmen; Raghav, Kanwal P.; Wang, Stephen E.; Lieu, Christopher H.... Journal: Journal of clinical oncology Issue: Volume 39:Issue 4(2021) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗